nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Extravasation—Carboplatin—esophageal cancer	0.0559	0.0559	CcSEcCtD
Iohexol—Motor dysfunction—Methotrexate—esophageal cancer	0.0541	0.0541	CcSEcCtD
Iohexol—Meningism—Methotrexate—esophageal cancer	0.0453	0.0453	CcSEcCtD
Iohexol—Blindness transient—Methotrexate—esophageal cancer	0.043	0.043	CcSEcCtD
Iohexol—Sensory disturbance—Capecitabine—esophageal cancer	0.034	0.034	CcSEcCtD
Iohexol—Amylase increased—Cisplatin—esophageal cancer	0.0301	0.0301	CcSEcCtD
Iohexol—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.0235	0.0235	CcSEcCtD
Iohexol—Haematoma—Capecitabine—esophageal cancer	0.0168	0.0168	CcSEcCtD
Iohexol—Extravasation—Cisplatin—esophageal cancer	0.0164	0.0164	CcSEcCtD
Iohexol—Thrombosis—Capecitabine—esophageal cancer	0.0149	0.0149	CcSEcCtD
Iohexol—Pain—Carboplatin—esophageal cancer	0.0149	0.0149	CcSEcCtD
Iohexol—Body temperature increased—Carboplatin—esophageal cancer	0.0138	0.0138	CcSEcCtD
Iohexol—Myocardial ischaemia—Capecitabine—esophageal cancer	0.0131	0.0131	CcSEcCtD
Iohexol—Injection site pain—Capecitabine—esophageal cancer	0.0129	0.0129	CcSEcCtD
Iohexol—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0107	0.0107	CcSEcCtD
Iohexol—Neck pain—Capecitabine—esophageal cancer	0.0107	0.0107	CcSEcCtD
Iohexol—Injection site reaction—Capecitabine—esophageal cancer	0.0105	0.0105	CcSEcCtD
Iohexol—Extravasation—Methotrexate—esophageal cancer	0.009	0.009	CcSEcCtD
Iohexol—Thrombophlebitis—Capecitabine—esophageal cancer	0.00885	0.00885	CcSEcCtD
Iohexol—Pancreatitis—Cisplatin—esophageal cancer	0.00881	0.00881	CcSEcCtD
Iohexol—Bone disorder—Methotrexate—esophageal cancer	0.0087	0.0087	CcSEcCtD
Iohexol—Swelling—Capecitabine—esophageal cancer	0.00868	0.00868	CcSEcCtD
Iohexol—Arthritis—Capecitabine—esophageal cancer	0.00788	0.00788	CcSEcCtD
Iohexol—Renal failure—Cisplatin—esophageal cancer	0.00787	0.00787	CcSEcCtD
Iohexol—Pain in extremity—Capecitabine—esophageal cancer	0.00766	0.00766	CcSEcCtD
Iohexol—Bradycardia—Cisplatin—esophageal cancer	0.00732	0.00732	CcSEcCtD
Iohexol—Cardiac arrest—Capecitabine—esophageal cancer	0.00728	0.00728	CcSEcCtD
Iohexol—Urinary tract disorder—Cisplatin—esophageal cancer	0.0071	0.0071	CcSEcCtD
Iohexol—Urethral disorder—Cisplatin—esophageal cancer	0.00705	0.00705	CcSEcCtD
Iohexol—Pulmonary oedema—Methotrexate—esophageal cancer	0.00699	0.00699	CcSEcCtD
Iohexol—Muscular weakness—Capecitabine—esophageal cancer	0.00676	0.00676	CcSEcCtD
Iohexol—Eye disorder—Cisplatin—esophageal cancer	0.00672	0.00672	CcSEcCtD
Iohexol—Flushing—Cisplatin—esophageal cancer	0.00667	0.00667	CcSEcCtD
Iohexol—Cardiac disorder—Cisplatin—esophageal cancer	0.00667	0.00667	CcSEcCtD
Iohexol—Thrombophlebitis—Methotrexate—esophageal cancer	0.00659	0.00659	CcSEcCtD
Iohexol—Bronchospasm—Capecitabine—esophageal cancer	0.00651	0.00651	CcSEcCtD
Iohexol—Immune system disorder—Cisplatin—esophageal cancer	0.00649	0.00649	CcSEcCtD
Iohexol—Mediastinal disorder—Cisplatin—esophageal cancer	0.00648	0.00648	CcSEcCtD
Iohexol—Arrhythmia—Cisplatin—esophageal cancer	0.00642	0.00642	CcSEcCtD
Iohexol—Erythema—Cisplatin—esophageal cancer	0.00626	0.00626	CcSEcCtD
Iohexol—Flatulence—Cisplatin—esophageal cancer	0.00617	0.00617	CcSEcCtD
Iohexol—Muscle spasms—Cisplatin—esophageal cancer	0.00602	0.00602	CcSEcCtD
Iohexol—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00589	0.00589	CcSEcCtD
Iohexol—Tremor—Cisplatin—esophageal cancer	0.00586	0.00586	CcSEcCtD
Iohexol—Renal failure—Capecitabine—esophageal cancer	0.0058	0.0058	CcSEcCtD
Iohexol—Malaise—Cisplatin—esophageal cancer	0.00564	0.00564	CcSEcCtD
Iohexol—Convulsion—Cisplatin—esophageal cancer	0.00542	0.00542	CcSEcCtD
Iohexol—Bradycardia—Capecitabine—esophageal cancer	0.00539	0.00539	CcSEcCtD
Iohexol—Discomfort—Cisplatin—esophageal cancer	0.00526	0.00526	CcSEcCtD
Iohexol—Urinary tract disorder—Capecitabine—esophageal cancer	0.00523	0.00523	CcSEcCtD
Iohexol—Urethral disorder—Capecitabine—esophageal cancer	0.00519	0.00519	CcSEcCtD
Iohexol—Anaphylactic shock—Cisplatin—esophageal cancer	0.00511	0.00511	CcSEcCtD
Iohexol—Nervous system disorder—Cisplatin—esophageal cancer	0.00501	0.00501	CcSEcCtD
Iohexol—Skin disorder—Cisplatin—esophageal cancer	0.00496	0.00496	CcSEcCtD
Iohexol—Eye disorder—Capecitabine—esophageal cancer	0.00495	0.00495	CcSEcCtD
Iohexol—Cardiac disorder—Capecitabine—esophageal cancer	0.00492	0.00492	CcSEcCtD
Iohexol—Flushing—Capecitabine—esophageal cancer	0.00492	0.00492	CcSEcCtD
Iohexol—Pancreatitis—Methotrexate—esophageal cancer	0.00483	0.00483	CcSEcCtD
Iohexol—Angiopathy—Capecitabine—esophageal cancer	0.00481	0.00481	CcSEcCtD
Iohexol—Immune system disorder—Capecitabine—esophageal cancer	0.00479	0.00479	CcSEcCtD
Iohexol—Mediastinal disorder—Capecitabine—esophageal cancer	0.00478	0.00478	CcSEcCtD
Iohexol—Hypotension—Cisplatin—esophageal cancer	0.00477	0.00477	CcSEcCtD
Iohexol—Arrhythmia—Capecitabine—esophageal cancer	0.00473	0.00473	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00465	0.00465	CcSEcCtD
Iohexol—Mental disorder—Capecitabine—esophageal cancer	0.00464	0.00464	CcSEcCtD
Iohexol—Erythema—Capecitabine—esophageal cancer	0.00461	0.00461	CcSEcCtD
Iohexol—Paraesthesia—Cisplatin—esophageal cancer	0.00459	0.00459	CcSEcCtD
Iohexol—Dyspnoea—Cisplatin—esophageal cancer	0.00455	0.00455	CcSEcCtD
Iohexol—Flatulence—Capecitabine—esophageal cancer	0.00455	0.00455	CcSEcCtD
Iohexol—Dysgeusia—Capecitabine—esophageal cancer	0.00452	0.00452	CcSEcCtD
Iohexol—Muscle spasms—Capecitabine—esophageal cancer	0.00444	0.00444	CcSEcCtD
Iohexol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00441	0.00441	CcSEcCtD
Iohexol—Pain—Cisplatin—esophageal cancer	0.00437	0.00437	CcSEcCtD
Iohexol—Tremor—Capecitabine—esophageal cancer	0.00432	0.00432	CcSEcCtD
Iohexol—Renal failure—Methotrexate—esophageal cancer	0.00432	0.00432	CcSEcCtD
Iohexol—Feeling abnormal—Cisplatin—esophageal cancer	0.00421	0.00421	CcSEcCtD
Iohexol—Malaise—Capecitabine—esophageal cancer	0.00416	0.00416	CcSEcCtD
Iohexol—Syncope—Capecitabine—esophageal cancer	0.00414	0.00414	CcSEcCtD
Iohexol—Loss of consciousness—Capecitabine—esophageal cancer	0.00405	0.00405	CcSEcCtD
Iohexol—Body temperature increased—Cisplatin—esophageal cancer	0.00404	0.00404	CcSEcCtD
Iohexol—Cough—Capecitabine—esophageal cancer	0.00403	0.00403	CcSEcCtD
Iohexol—Hypertension—Capecitabine—esophageal cancer	0.00398	0.00398	CcSEcCtD
Iohexol—Arthralgia—Capecitabine—esophageal cancer	0.00393	0.00393	CcSEcCtD
Iohexol—Urinary tract disorder—Methotrexate—esophageal cancer	0.0039	0.0039	CcSEcCtD
Iohexol—Discomfort—Capecitabine—esophageal cancer	0.00388	0.00388	CcSEcCtD
Iohexol—Urethral disorder—Methotrexate—esophageal cancer	0.00387	0.00387	CcSEcCtD
Iohexol—Confusional state—Capecitabine—esophageal cancer	0.0038	0.0038	CcSEcCtD
Iohexol—Hypersensitivity—Cisplatin—esophageal cancer	0.00376	0.00376	CcSEcCtD
Iohexol—Shock—Capecitabine—esophageal cancer	0.0037	0.0037	CcSEcCtD
Iohexol—Nervous system disorder—Capecitabine—esophageal cancer	0.00369	0.00369	CcSEcCtD
Iohexol—Eye disorder—Methotrexate—esophageal cancer	0.00369	0.00369	CcSEcCtD
Iohexol—Cardiac disorder—Methotrexate—esophageal cancer	0.00366	0.00366	CcSEcCtD
Iohexol—Skin disorder—Capecitabine—esophageal cancer	0.00366	0.00366	CcSEcCtD
Iohexol—Angiopathy—Methotrexate—esophageal cancer	0.00358	0.00358	CcSEcCtD
Iohexol—Immune system disorder—Methotrexate—esophageal cancer	0.00356	0.00356	CcSEcCtD
Iohexol—Mediastinal disorder—Methotrexate—esophageal cancer	0.00356	0.00356	CcSEcCtD
Iohexol—Hypotension—Capecitabine—esophageal cancer	0.00352	0.00352	CcSEcCtD
Iohexol—Diarrhoea—Cisplatin—esophageal cancer	0.00349	0.00349	CcSEcCtD
Iohexol—Mental disorder—Methotrexate—esophageal cancer	0.00346	0.00346	CcSEcCtD
Iohexol—Erythema—Methotrexate—esophageal cancer	0.00343	0.00343	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00343	0.00343	CcSEcCtD
Iohexol—Paraesthesia—Capecitabine—esophageal cancer	0.00338	0.00338	CcSEcCtD
Iohexol—Dysgeusia—Methotrexate—esophageal cancer	0.00336	0.00336	CcSEcCtD
Iohexol—Dyspnoea—Capecitabine—esophageal cancer	0.00336	0.00336	CcSEcCtD
Iohexol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00325	0.00325	CcSEcCtD
Iohexol—Vomiting—Cisplatin—esophageal cancer	0.00325	0.00325	CcSEcCtD
Iohexol—Rash—Cisplatin—esophageal cancer	0.00322	0.00322	CcSEcCtD
Iohexol—Pain—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Iohexol—Dermatitis—Cisplatin—esophageal cancer	0.00322	0.00322	CcSEcCtD
Iohexol—Feeling abnormal—Capecitabine—esophageal cancer	0.0031	0.0031	CcSEcCtD
Iohexol—Malaise—Methotrexate—esophageal cancer	0.0031	0.0031	CcSEcCtD
Iohexol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00308	0.00308	CcSEcCtD
Iohexol—Nausea—Cisplatin—esophageal cancer	0.00303	0.00303	CcSEcCtD
Iohexol—Cough—Methotrexate—esophageal cancer	0.003	0.003	CcSEcCtD
Iohexol—Urticaria—Capecitabine—esophageal cancer	0.00299	0.00299	CcSEcCtD
Iohexol—Body temperature increased—Capecitabine—esophageal cancer	0.00298	0.00298	CcSEcCtD
Iohexol—Abdominal pain—Capecitabine—esophageal cancer	0.00298	0.00298	CcSEcCtD
Iohexol—Convulsion—Methotrexate—esophageal cancer	0.00298	0.00298	CcSEcCtD
Iohexol—Arthralgia—Methotrexate—esophageal cancer	0.00292	0.00292	CcSEcCtD
Iohexol—Discomfort—Methotrexate—esophageal cancer	0.00289	0.00289	CcSEcCtD
Iohexol—Confusional state—Methotrexate—esophageal cancer	0.00283	0.00283	CcSEcCtD
Iohexol—Anaphylactic shock—Methotrexate—esophageal cancer	0.0028	0.0028	CcSEcCtD
Iohexol—Hypersensitivity—Capecitabine—esophageal cancer	0.00277	0.00277	CcSEcCtD
Iohexol—Nervous system disorder—Methotrexate—esophageal cancer	0.00275	0.00275	CcSEcCtD
Iohexol—Skin disorder—Methotrexate—esophageal cancer	0.00272	0.00272	CcSEcCtD
Iohexol—Pruritus—Capecitabine—esophageal cancer	0.00266	0.00266	CcSEcCtD
Iohexol—Hypotension—Methotrexate—esophageal cancer	0.00262	0.00262	CcSEcCtD
Iohexol—Diarrhoea—Capecitabine—esophageal cancer	0.00258	0.00258	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00255	0.00255	CcSEcCtD
Iohexol—Paraesthesia—Methotrexate—esophageal cancer	0.00252	0.00252	CcSEcCtD
Iohexol—Dyspnoea—Methotrexate—esophageal cancer	0.0025	0.0025	CcSEcCtD
Iohexol—Somnolence—Methotrexate—esophageal cancer	0.00249	0.00249	CcSEcCtD
Iohexol—Dizziness—Capecitabine—esophageal cancer	0.00249	0.00249	CcSEcCtD
Iohexol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00242	0.00242	CcSEcCtD
Iohexol—Pain—Methotrexate—esophageal cancer	0.0024	0.0024	CcSEcCtD
Iohexol—Vomiting—Capecitabine—esophageal cancer	0.00239	0.00239	CcSEcCtD
Iohexol—Rash—Capecitabine—esophageal cancer	0.00237	0.00237	CcSEcCtD
Iohexol—Dermatitis—Capecitabine—esophageal cancer	0.00237	0.00237	CcSEcCtD
Iohexol—Headache—Capecitabine—esophageal cancer	0.00236	0.00236	CcSEcCtD
Iohexol—Feeling abnormal—Methotrexate—esophageal cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00229	0.00229	CcSEcCtD
Iohexol—Nausea—Capecitabine—esophageal cancer	0.00224	0.00224	CcSEcCtD
Iohexol—Urticaria—Methotrexate—esophageal cancer	0.00223	0.00223	CcSEcCtD
Iohexol—Abdominal pain—Methotrexate—esophageal cancer	0.00222	0.00222	CcSEcCtD
Iohexol—Body temperature increased—Methotrexate—esophageal cancer	0.00222	0.00222	CcSEcCtD
Iohexol—Hypersensitivity—Methotrexate—esophageal cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Pruritus—Methotrexate—esophageal cancer	0.00198	0.00198	CcSEcCtD
Iohexol—Diarrhoea—Methotrexate—esophageal cancer	0.00192	0.00192	CcSEcCtD
Iohexol—Dizziness—Methotrexate—esophageal cancer	0.00185	0.00185	CcSEcCtD
Iohexol—Vomiting—Methotrexate—esophageal cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Rash—Methotrexate—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Dermatitis—Methotrexate—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Headache—Methotrexate—esophageal cancer	0.00176	0.00176	CcSEcCtD
Iohexol—Nausea—Methotrexate—esophageal cancer	0.00166	0.00166	CcSEcCtD
